Ubs Group Ag Merck & Co., Inc. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ubs Group Ag holds 21,061,269 shares of MRK stock, worth $1.72 Billion. This represents 0.36% of its overall portfolio holdings.
Number of Shares
21,061,269
Previous 689,370
2955.15%
Holding current value
$1.72 Billion
Previous $68.6 Million
2656.66%
% of portfolio
0.36%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,876Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$20.6 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.83 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.66 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.86 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $207B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...